BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29524476)

  • 1. Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study.
    Russo V; Papa AA; Rago A; Ciardiello C; Nigro G
    Heart Rhythm; 2018 Jul; 15(7):962-968. PubMed ID: 29524476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
    Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
    Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study.
    Nigro G; Russo V; Rago A; Antonio Papa A; Palladino A; Politano L
    Acta Myol; 2012 Oct; 31(2):139-43. PubMed ID: 23097606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
    Russo V; Rago A; Papa AA; Politano L; Golino P; Russo MG; Calabrò R; Nigro G
    Kardiol Pol; 2013; 71(11):1147-53. PubMed ID: 24297712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.
    Russo V; Rago A; Politano L; Della Cioppa N; Russo MG; Golino P; Calabrò R; Nigro G
    Europace; 2012 Apr; 14(4):486-9. PubMed ID: 22135319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up.
    Russo V; Nigro G; Rago A; Antonio Papa A; Proietti R; Della Cioppa N; Cristiano A; Palladino A; Calabrò R; Politano L
    Acta Myol; 2013 Dec; 32(3):142-7. PubMed ID: 24803841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial.
    Boriani G; Tukkie R; Biffi M; Mont L; Ricci R; Pürerfellner H; Botto GL; Manolis AS; Landolina M; Gulizia M; Hudnall JH; Mangoni L; Grammatico A; Padeletti L;
    Heart Rhythm; 2017 Oct; 14(10):1476-1484. PubMed ID: 28506917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients.
    Russo V; Rago A; Papa AA; Arena G; Politano L; Nigro G
    J Interv Card Electrophysiol; 2018 Apr; 51(3):229-236. PubMed ID: 29488106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1.
    Russo V; Papa AA; Rago A; Ciardiello C; Marano M; Proietti R; Politano L; Nigro G
    Neuromuscul Disord; 2018 Apr; 28(4):327-333. PubMed ID: 29567351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study.
    Nigro G; Russo V; Politano L; Della Cioppa N; Rago A; Arena G; Papa AA; Paoli LD; de Chiara A; Russo MG; Golino P; Calabrò R
    Europace; 2010 Sep; 12(9):1219-23. PubMed ID: 20538830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.
    Veasey RA; Arya A; Freemantle N; Silberbauer J; Patel NR; Lloyd GW; Sulke AN
    J Interv Card Electrophysiol; 2010 Jun; 28(1):51-7. PubMed ID: 20082131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
    Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L;
    Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
    Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S;
    Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
    Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
    Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.